Skip to main content
Clinical Trials/DRKS00032726
DRKS00032726
Completed
未知

Study to investigate the influence of different coatings on the esophageal transit of tablets - MRI_EsoCoatings

Institut für Pharmazie, Abteilung Biopharmazie und Pharmazeutische Technologie0 sites36 target enrollmentMarch 13, 2024

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Institut für Pharmazie, Abteilung Biopharmazie und Pharmazeutische Technologie
Enrollment
36
Status
Completed
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 13, 2024
End Date
January 22, 2024
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Institut für Pharmazie, Abteilung Biopharmazie und Pharmazeutische Technologie

Eligibility Criteria

Inclusion Criteria

  • BMI: 18 – 30 kg/m² .
  • Signed written informed consent.
  • Good health as evidenced by the results of the inclusion anamnesis which does not differ in a clinically relevant way from the normal state and does not implicate a disease requiring long\-term medication.

Exclusion Criteria

  • ? Patients with dysphagia
  • ? Patients with swallowing difficulties in respect to solid oral dosage forms which do not allow safe and reliable study participation
  • ? Any contraindications to MRI imaging including, in particular, implants containing metal (except dental retainers), pacemakers, brain aneurysm clips, brain or pacemaker leads, implanted defilibrators, artificial heart valves, cochlear implants, foreign bodies in the eye, implanted insulin pumps, large and dark tattoos, and claustrophobia
  • ? Known intolerance against any of the dosage form materials
  • ? Alcohol and drug dependency
  • ? Concomitant medication with drugs known to affect gastrointestinal function in particular:
  • o Laxatives
  • o Antidiarrheal
  • o Prokinetics
  • o Antiemetics

Outcomes

Primary Outcomes

Not specified

Similar Trials